Kelly McBride is the NPR Public Editor, the public's representative to NPR. She serves as an independent voice on questions raised by listeners and readers of news broadcast and published by NPR. You ...

The top three teams separate themselves from the rest of the field and a new team has joined the Top 10 after Week 1 of the ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...